1. Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis

   • Slavko Rogan
   • Jan Taeymans
   • Nick Gebruers

   Review 26 July 2016 Pages: 1 - 14

   

2. Bilateral mastectomy and the retreat from breast-conserving surgery

   • Frederick L. Moffat Jr.
   • Danny Yakoub

   Review 30 July 2016 Pages: 15 - 30

   

3. Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines

   • Xiao-Long Qian
   • Hannah Y. Wen
   • Li Fu

   Preclinical study 25 July 2016 Pages: 31 - 39

   

4. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

   • Alaa Tarig Alshareeda
   • Ola H. Negm
   • Emad A. Rakha

   Preclinical study 27 July 2016 Pages: 41 - 53

   

5. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma

   • Cheol Keun Park
   • Woo Hee Jung
   • Ja Seung Koo

   Preclinical study 28 July 2016 Pages: 55 - 69

   

6. Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors

   • Ivana Sestak
   • Mitch Dowsett
   • Jack Cuzick

   Clinical Trial Open access 22 July 2016 Pages: 71 - 78

   

7. Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy

   • Alessandra Gennari
   • Dino Amadori
   • Oriana Nanni

   Clinical trial 26 July 2016 Pages: 79 - 86

   

8. Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622

   • Anne F. Schott
   • William E. Barlow
   • Gabriel N. Hortobagyi

   Clinical trial 30 July 2016 Pages: 87 - 95

   

9. A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen

   • Harriet Johansson
   • Sara Gandini
   • Bernardo Bonanni

   Clinical trial 02 August 2016 Pages: 97 - 108

   

10. Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426)

    • Erica T. Warner
    • Karla V. Ballman
    • Ann H. Partridge

    Epidemiology 22 July 2016 Pages: 109 - 118

11. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study

    • Marilyn L. Kwan
    • Song Yao
    • Lawrence H. Kushi

    Epidemiology 22 July 2016 Pages: 119 - 129

    

12. A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago

    • Talia Donenberg
    • Humayun Ahmed
    • Judith Hurley

    Epidemiology 28 July 2016 Pages: 131 - 138

    

13. Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal women

    • Fred K. Tabung
    • Susan E. Steck
    • James R. Hebert

    Epidemiology 30 July 2016 Pages: 139 - 149

14. Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab

    • Ines Vaz-Luis
    • Nancy U. Lin
    • Rachel A. Freedman

    Epidemiology 02 August 2016 Pages: 151 - 162

    

15. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study

    • Jonine D. Figueroa
    • Ruth M. Pfeiffer
    • Mark E. Sherman

    Epidemiology 03 August 2016 Pages: 163 - 172

    

16. Lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer

    • William B. Grant

    Letter to the Editor 25 July 2016 Pages: 173 - 173

17. Author’s response to “letter to the editor: lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer”

    • Christine Leopold

    Rebuttal Letter 28 July 2016 Pages: 175 - 175

18. UK Breast Cancer Research Symposium 2016: Submitted Abstracts

    Abstracts Open access 20 August 2016 Pages: 177 - 197

19. Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer

    • Andrew R. Green
    • D. Soria
    • I. O. Ellis

    Erratum 22 July 2016 Pages: 199 - 199

20. Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer

    • Kenneth L. Kehl
    • Chan Shen
    • Sharon H. Giordano

    Erratum 27 July 2016 Pages: 201 - 201